LENGTH OF PROGRAM:
The CTRC at UTHSCSA provides treatment, research and education/prevention to citizens throughout South Texas and the world. The CTRC is one of a few elite cancer centers in the country to be named a NCI Designated Cancer Center, and is one of three in the state of Texas.
The CTRC Institute for Drug Development, an internationally known center for the development of anti-cancer drugs, maintains the largest Phase I clinical studies program in the country. These studies mark the first time the U.S. Food and Drug Administration approves the use of new anti-cancer drugs in human beings.
The CTRC’s focus on compassionate care is enhanced by our commitment to provide the latest technology and the time and resources to facilitate the discovery of the causes, prevention, treatment, and conquest of cancer. Our comprehensive cancer care offers a full spectrum of clinical and support services to meet the medical, nutritional, emotional and spiritual needs of the patient (and family), from diagnosis through treatment, rehabilitation and follow-up care.
Major areas of clinical involvement for the resident are supportive care and prevention or management of antineoplastic drug toxicity. Accordingly, oncology pharmacists are involved in nausea and vomiting prevention, pain management, infection treatment, nutritional support, antineoplastic toxicity prevention and management, therapeutic drug monitoring, and chemotherapy regimen dosing and design. These services are provided to the medical oncology, hematology and research clinics. Inpatient experiences are proved through the South Texas Veterans Healthcare System, University Hospital, and Christus Santa Rosa Medical Center Hospital. Other areas of involvement are coordination and supervision of chemotherapy preparation, patient and staff education, investigational drug control, and provision of drug information. Oncology Pharmacy Residents are involved in all of these activities to ensure the development of a clinician with comprehensive oncology pharmacy skills. Teaching and clinical research opportunities are also available.
Research opportunities for those interested in the Masters or PhD programs are tailored to the trainee’s interest. Programs include, but are not limited to, pharmacoeconomics/outcomes research, drug development, and other oncology related areas of research.
Responsibilities and activities are structured to meet or exceed ASHP standards for oncology pharmacy practice. Residency training is provided under the supervision of Scott Soefje, Pharm.D., BCOP, Anita Garcia, Pharm.D., BCOP, Bradi Frei, Pharm.D., BCPS, BCOP and others as necessary to meet goals and objectives. A Masters or PhD candidate will work with a faculty from the College of Pharmacy.The resident is an employee of the University of Texas at Austin College of Pharmacy. The University of Texas at Austin and its affiliated institutions are an Equal Opportunity/Affirmative Action Employer. Qualified women and minorities are encouraged to apply. Security sensitive; conviction verification conducted on applicant selected.
College of Pharmacy
The University of Texas
2409 University Ave.
Austin, TX, USA
Email Address: pharmacy
For specific programs, contact: